IRWD — Ironwood Pharmaceuticals, Inc. stock price, charts and financials

QT90Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.31
-0.11-2.49%
OverviewShort InterestFilings
IRWDQT90Ironwood Pharmaceuticals, Inc.·NASDAQ
4.31-2.49%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 22, 20263Initial statement of beneficial ownership
Jul 22, 20264Statement of changes in beneficial ownership
Jul 09, 20264Statement of changes in beneficial ownership
Jun 18, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 15, 20268-KCurrent report
May 21, 20268-K/ACurrent report (amended)
May 21, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20268-KCurrent report
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
Apr 28, 2026DEF 14ADefinitive proxy statement
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 28, 2026ARSAnnual report to shareholders
Apr 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 359
Page
▼
/ 15